Calendar

pharmadog

Week of Feb 23, 2026

Feb 24, 2026approval171d agoROBINUL (GLYCOPYRROLATE) — FDA approvalGLYCOPYRROLATE

Sponsor: HIKMA. Form: INJECTABLE. Route: INJECTION

full page →GLYCOPYRROLATE →fda approvals ↗

Feb 24, 2026approval171d agoCLOMIPHENE CITRATE — FDA approvalCLOMIPHENE CITRATE

Sponsor: COSETTE. Form: TABLET. Route: ORAL

full page →CLOMIPHENE CITRATE →fda approvals ↗

Feb 24, 2026approval171d agoLURASIDONE HYDROCHLORIDE — FDA approvalSumitomo Pharma America Inc

Sponsor: CHARTWELL RX. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Feb 24, 2026approval171d agoLURASIDONE HYDROCHLORIDE — FDA approvalSumitomo Pharma America Inc

Sponsor: CHARTWELL RX. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Feb 24, 2026approval171d agoMICAFUNGIN SODIUM — FDA approvalMICAFUNGIN SODIUM

Sponsor: YICHANG HUMANWELL. Form: INJECTABLE. Route: INTRAVENOUS

full page →MICAFUNGIN SODIUM →fda approvals ↗

Feb 24, 2026approval171d agoFOLLISTIM AQ (FOLLITROPIN ALFA/BETA) — FDA approvalfollitropin beta

Sponsor: ORGANON USA LLC. Form: INJECTABLE. Route: SUBCUTANEOUS

full page →follitropin beta →fda approvals ↗

Feb 24, 2026approval171d agoFINGOLIMOD HYDROCHLORIDE — FDA approvalFINGOLIMOD HYDROCHLORIDE

Sponsor: AUROBINDO PHARMA LTD. Form: CAPSULE. Route: ORAL

full page →FINGOLIMOD HYDROCHLORIDE →fda approvals ↗

Feb 24, 2026approval171d agoLIRAGLUTIDE — FDA approvalSaxenda

Sponsor: BIOCON PHARMA. Form: SOLUTION. Route: SUBCUTANEOUS

full page →Saxenda →fda approvals ↗

Feb 24, 2026approval171d agoBRAFTOVI (ENCORAFENIB) — FDA approvalencorafenib

Sponsor: ARRAY BIOPHARMA INC. Form: CAPSULE. Route: ORAL

full page →encorafenib →fda approvals ↗

Feb 24, 2026approval171d agoBRAFTOVI (ENCORAFENIB) — FDA approvalencorafenib

Sponsor: ARRAY BIOPHARMA INC. Form: CAPSULE. Route: ORAL

full page →encorafenib →fda approvals ↗

Feb 24, 2026approval171d agoPREGABALIN — FDA approvalViatris Inc

Sponsor: FOURRTS LABS. Form: CAPSULE. Route: ORAL

full page →fda approvals ↗

Feb 24, 2026approval171d agoMUPIROCIN — FDA approvalFougera Pharmaceuticals Inc

Sponsor: FOUGERA PHARMS. Form: OINTMENT. Route: TOPICAL

full page →fda approvals ↗

Feb 24, 2026approval171d agoMUPIROCIN — FDA approvalFougera Pharmaceuticals Inc

Sponsor: FOUGERA PHARMS. Form: OINTMENT. Route: TOPICAL

full page →fda approvals ↗

Feb 24, 2026approval171d agoMUPIROCIN — FDA approvalFougera Pharmaceuticals Inc

Sponsor: FOUGERA PHARMS. Form: OINTMENT. Route: TOPICAL

full page →fda approvals ↗

Feb 24, 2026approval171d agoGABAPENTIN — FDA approvalAlmatica Pharma LLC

Sponsor: IPCA LABS LTD. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Feb 24, 2026approval171d agoLIRAGLUTIDE — FDA approvalNovo Nordisk Inc

Sponsor: ORBICULAR. Form: SOLUTION. Route: SUBCUTANEOUS

full page →fda approvals ↗

Feb 25, 2026approval170d agoWEGOVY (SEMAGLUTIDE) — FDA approvalNovo Nordisk AS

Sponsor: NOVO. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Feb 25, 2026approval170d agoWEGOVY (SEMAGLUTIDE) — FDA approvalNovo Nordisk AS

Sponsor: NOVO. Form: SOLUTION. Route: SUBCUTANEOUS

full page →fda approvals ↗

Feb 25, 2026approval170d agoSAXENDA (LIRAGLUTIDE) — FDA approvalNovo Nordisk Inc

Sponsor: NOVO. Form: SOLUTION. Route: SUBCUTANEOUS

full page →fda approvals ↗

Feb 25, 2026approval170d agoZIOPTAN (TAFLUPROST) — FDA approvaltafluprost

Sponsor: THEA PHARMA. Form: SOLUTION/DROPS. Route: OPHTHALMIC

full page →tafluprost →fda approvals ↗

Feb 25, 2026approval170d agoZEPBOUND (TIRZEPATIDE) — FDA approvalZEPBOUND

Sponsor: ELI LILLY AND CO. Form: SOLUTION. Route: SUBCUTANEOUS

full page →ZEPBOUND →fda approvals ↗

Feb 25, 2026approval170d agoENTYVIO (VEDOLIZUMAB) — FDA approvalTakeda Pharmaceuticals USA Inc

Sponsor: TAKEDA PHARMS USA. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

Feb 25, 2026approval170d agoDEXMEDETOMIDINE HYDROCHLORIDE — FDA approvalBioXcel Therapeutics, Inc.

Sponsor: DR REDDYS. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

Feb 25, 2026approval170d agoHYDROCORTISONE — FDA approvalET-800

Sponsor: APPCO. Form: TABLET. Route: ORAL

full page →ET-800 →fda approvals ↗

Feb 25, 2026approval170d agoCETIRIZINE HYDROCHLORIDE — FDA approvalCETIRIZINE HYDROCHLORIDE

Sponsor: RUBICON RESEARCH. Form: SOLUTION. Route: ORAL

full page →CETIRIZINE HYDROCHLORIDE →fda approvals ↗

Feb 25, 2026approval170d agoBUPROPION HYDROCHLORIDE — FDA approvalSenores Pharmaceuticals Inc

Sponsor: SENORES PHARMS. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Feb 25, 2026approval170d agoONDANSETRON HYDROCHLORIDE — FDA approvalondansetron hydrochloride CR

Sponsor: DR REDDYS LABS LTD. Form: TABLET. Route: ORAL

full page →ondansetron hydrochloride CR →fda approvals ↗

Feb 25, 2026approval170d agoEVEROLIMUS — FDA approvalPostsurgical Therapeutics Inc

Sponsor: EUGIA PHARMA. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Feb 25, 2026approval170d agoANASTROZOLE — FDA approvalStason Pharmaceuticals Inc

Sponsor: BEIJING YILING. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Feb 25, 2026approval170d agoONDANSETRON HYDROCHLORIDE — FDA approvalondansetron hydrochloride CR

Sponsor: RISING. Form: TABLET. Route: ORAL

full page →ondansetron hydrochloride CR →fda approvals ↗

Feb 25, 2026approval170d agoENTYVIO (VEDOLIZUMAB) — FDA approvalTakeda Pharmaceuticals USA Inc

Sponsor: TAKEDA PHARMS USA. Form: INJECTABLE. Route: INTRAVENOUS

full page →fda approvals ↗

Feb 25, 2026approval170d agoJUXTAPID (LOMITAPIDE MESYLATE) — FDA approvalChiesi USA Inc

Sponsor: CHIESI. Form: CAPSULE. Route: ORAL

full page →fda approvals ↗

Feb 25, 2026approval170d agoDESMODA (DESMOPRESSIN ACETATE) — FDA approvaldesmopressin acetate

Sponsor: ETON. Form: SOLUTION. Route: ORAL

full page →desmopressin acetate →fda approvals ↗

Feb 25, 2026approval170d agoLAMOTRIGINE — FDA approvalLAMOTRIGINE

Sponsor: ALEMBIC. Form: TABLET, ORALLY DISINTEGRATING. Route: ORAL

full page →LAMOTRIGINE →fda approvals ↗

Feb 26, 2026approval169d agoXeomin (incobotulinumtoxinA) — FDA approvalMerz Pharmaceuticals LLC

Sponsor: MERZ PHARMS. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

Feb 26, 2026approval169d agoDAPSONE — FDA approvalDAPSONE

Sponsor: ZYDUS LIFESCIENCES. Form: TABLET. Route: ORAL

full page →DAPSONE →fda approvals ↗

Feb 26, 2026approval169d agoJASCAYD (NERANDOMILAST) — FDA approvalnerandomilast

Sponsor: BOEHRINGER INGELHEIM. Form: TABLET. Route: ORAL

full page →nerandomilast →fda approvals ↗

Feb 26, 2026approval169d agoVYVGART HYTRULO (EFGARTIGIMOD ALFA AND HYALURONIDASE-QVFC) — FDA approvalARGENX SE

Sponsor: ARGENX BV. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

Feb 26, 2026approval169d agoBUMETANIDE — FDA approvalEdenbridge Pharmaceuticals LLC

Sponsor: ANTHEA PHARMA. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

Feb 26, 2026approval169d agoPHYTONADIONE — FDA approvalPHYTONADIONE

Sponsor: SINOTHERAPEUTICS INC. Form: TABLET. Route: ORAL

full page →PHYTONADIONE →fda approvals ↗

Feb 26, 2026approval169d agoONDANSETRON HYDROCHLORIDE — FDA approvalRedHill Biopharma Ltd.

Sponsor: TARO. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Feb 26, 2026approval169d agoONDANSETRON HYDROCHLORIDE — FDA approvalRedHill Biopharma Ltd.

Sponsor: TARO. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Feb 26, 2026approval169d agoHERNEXEOS (ZONGERTINIB) — FDA approvalzongertinib

Sponsor: BOEHRINGER INGELHEIM. Form: TABLET. Route: ORAL

full page →zongertinib →fda approvals ↗

Feb 26, 2026approval169d agoRIZAFILM (RIZATRIPTAN BENZOATE) — FDA approvalNAL Pharmaceuticals Ltd

Sponsor: GENSCO. Form: FILM. Route: ORAL

full page →fda approvals ↗

Feb 26, 2026approval169d agoDALBAVANCIN HYDROCHLORIDE — FDA approvalLong Grove Pharmaceuticals LLC

Sponsor: LONG GROVE PHARMS. Form: POWDER. Route: INTRAVENOUS

full page →fda approvals ↗

Feb 26, 2026approval169d agoENSACOVE (ENSARTINIB HYDROCHLORIDE) — FDA approvalensartinib hydrochloride

Sponsor: XCOVERY. Form: CAPSULE. Route: ORAL

full page →ensartinib hydrochloride →fda approvals ↗

Feb 26, 2026approval169d agoPHYTONADIONE — FDA approvalPHYTONADIONE

Sponsor: BAXTER HLTHCARE CORP. Form: INJECTABLE. Route: INJECTION

full page →PHYTONADIONE →fda approvals ↗

Feb 26, 2026approval169d agoIVERMECTIN — FDA approvalIVERMECTIN

Sponsor: ZYDUS LIFESCIENCES. Form: TABLET. Route: ORAL

full page →IVERMECTIN →fda approvals ↗

Feb 27, 2026approval168d agoPREZCOBIX (DARUNAVIR AND COBICISTAT) — FDA approvalGILEAD SCIENCES, INC.

Sponsor: JANSSEN PRODS. Form: TABLET, FOR SUSPENSION. Route: ORAL

full page →fda approvals ↗

Feb 27, 2026approval168d agoDILTIAZEM HYDROCHLORIDE — FDA approvalDILTIAZEM HYDROCHLORIDE

Sponsor: MACLEODS PHARMS LTD. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL

full page →DILTIAZEM HYDROCHLORIDE →fda approvals ↗

← prev

page 1 of 15

Week of Feb 23, 2026